Gandhar Oil Refinery (India) Limited has released its Investor Presentation for the Quarter and Nine Months ended December 31, 2025 (Q3 FY 2025-26). The presentation includes un-audited financial results on both standalone and consolidated bases. The company highlighted its strong market position as India's largest white oil player and one of the top five globally. The Personal Care, Healthcare, and Performance Oils (PHPO) division remains the largest business segment, contributing approximately 47.3% of revenues from finished goods sold in FY25. This division has shown robust growth, with revenue growing at a CAGR of 23.8% and sales volume at a CAGR of 13.3% during FY21-25. Primary end-industries for PHPO are Consumer and Healthcare, accounting for 68.2% of its revenue in FY25. Gandhar Oil serves a diversified customer base, including major Indian and global companies like Procter & Gamble, Unilever, Marico, and Dabur. The company's financial performance for Q3 FY26 shows Revenue from Operations at ₹1,167.0 crore, an increase from ₹1,005.3 crore in Q3 FY25. EBITDA stood at ₹59.1 crore, and Profit After Tax was ₹34.3 crore. For the nine months ended December 31, 2025 (9MFY26), Revenue from Operations was ₹3,129.9 crore, with a Profit After Tax of ₹100.2 crore. Gandhar Oil operates three strategically located manufacturing facilities in Taloja (Maharashtra), Silvassa (Dadra and Nagar Haveli), and Sharjah (UAE), with a total capacity of 597,403 KL. The company emphasizes its resilient business model and prudent risk management framework, including strategies for commodity price risk, foreign exchange risk, and credit risk mitigation. Future growth strategies focus on enhancing its presence in consumer and healthcare end-industries, increasing overseas sales by expanding product offerings and penetrating new geographies, and strengthening its customer base by growing existing business and acquiring new customers. The company also aims to move up the value chain by expanding its contract manufacturing services.
